Cancer Epidemiology Biomarkers & Prevention, Vol 5, Issue 6 473-475, Copyright © 1996 by American Association for Cancer Research

ARTICLES

Simian virus 40 and pleural mesothelioma in humans

HD Strickler, JJ Goedert, M Fleming, WD Travis, AE Williams, CS Rabkin, RW Daniel and KV Shah
Viral Epidemiology Branch, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA.

It has been reported that DNA of SV40, a virus of Asian macaques that is tumorigenic for rodents and can transform human cells in vitro, is present in pleural mesotheliomas and in several other cancers. To verify these observations, we tested paraffin sections from mesothelioma tissues of 50 patients for SV40 DNA using PCR with two separate sets of primers. The analytic sensitivity for detection of SV40 DNA was 1-10 genome copies. We also tested the specimens for beta-globin by PCR to assess the suitability of the specimen DNAs for amplification. beta-Globin amplification was detected in 48 of the 50 specimens, but SV40 DNA was not detected in any tumors, with either of two SV40 primer sets. Furthermore, sera from 34 additional patients with mesothelioma, 33 patients with osteosarcoma (another cancer reported to be SV40-related) and 35 controls were tested for SV40 antibodies by a plaque neutralization assay. The serological data, like the DNA results, did not support an association of SV40 with mesothelioma or with osteosarcoma; antibodies to SV40 were detected in three mesothelioma patients, in one osteosarcoma patient, and in one control. These findings call into question the association of SV40 with mesothelioma.

This article has been cited by other articles:

				D. L. Poulin and J. A. DeCaprio Is There a Role for SV40 in Human Cancer? J. Clin. Oncol., September 10, 2006; 24(26): 4356 - 4365. [Abstract] [Full Text] [PDF]

				J. J. Manfredi, J. Dong, W.-j. Liu, L. Resnick-Silverman, R. Qiao, P. Chahinian, M. Saric, A. R. Gibbs, J. I. Phillips, J. Murray, et al. Evidence against a Role for SV40 in Human Mesothelioma Cancer Res., April 1, 2005; 65(7): 2602 - 2609. [Abstract] [Full Text] [PDF]

				E. A. Engels, J. Chen, R. P. Viscidi, K. V. Shah, R. W. Daniel, N. Chatterjee, and M. A. Klebanoff Poliovirus Vaccination during Pregnancy, Maternal Seroconversion to Simian Virus 40, and Risk of Childhood Cancer Am. J. Epidemiol., August 15, 2004; 160(4): 306 - 316. [Abstract] [Full Text] [PDF]

				D. E. M. Rollison, W. F. Page, H. Crawford, G. Gridley, S. Wacholder, J. Martin, R. Miller, and E. A. Engels Case-Control Study of Cancer among US Army Veterans Exposed to Simian Virus 40-contaminated Adenovirus Vaccine Am. J. Epidemiol., August 15, 2004; 160(4): 317 - 324. [Abstract] [Full Text] [PDF]

				R. A. Vilchez and J. S. Butel Emergent Human Pathogen Simian Virus 40 and Its Role in Cancer Clin. Microbiol. Rev., July 1, 2004; 17(3): 495 - 508. [Abstract] [Full Text] [PDF]

				J. J. Carter, M. M. Madeleine, G. C. Wipf, R. L. Garcea, P. A. Pipkin, P. D. Minor, and D. A. Galloway Lack of Serologic Evidence for Prevalent Simian Virus 40 Infection in Humans J Natl Cancer Inst, October 15, 2003; 95(20): 1522 - 1530. [Abstract] [Full Text] [PDF]

				F Mayall, K Barratt, and J Shanks The detection of Simian virus 40 in mesotheliomas from New Zealand and England using real time FRET probe PCR protocols J. Clin. Pathol., October 1, 2003; 56(10): 728 - 730. [Abstract] [Full Text] [PDF]

				R. L. Garcea and M. J. Imperiale Simian Virus 40 Infection of Humans J. Virol., May 1, 2003; 77(9): 5039 - 5045. [Full Text] [PDF]

				E. A. Engels, H. A. Katki, N. M. Nielsen, J. F. Winther, H. Hjalgrim, F. Gjerris, P. S. Rosenberg, and M. Frisch Cancer Incidence in Denmark Following Exposure to Poliovirus Vaccine Contaminated With Simian Virus 40 J Natl Cancer Inst, April 2, 2003; 95(7): 532 - 539. [Abstract] [Full Text] [PDF]

				R. P. Viscidi, D. E. M. Rollison, E. Viscidi, B. Clayman, E. Rubalcaba, R. Daniel, E. O. Major, and K. V. Shah Serological Cross-Reactivities between Antibodies to Simian Virus 40, BK Virus, and JC Virus Assessed by Virus-Like-Particle-Based Enzyme Immunoassays Clin. Vaccine Immunol., March 1, 2003; 10(2): 278 - 285. [Abstract] [Full Text] [PDF]

				H. D. Strickler, J. J. Goedert, S. S. Devesa, J. Lahey, J. F. Fraumeni Jr., and P. S. Rosenberg Trends in U.S. Pleural Mesothelioma Incidence Rates Following Simian Virus 40 Contamination of Early Poliovirus Vaccines J Natl Cancer Inst, January 1, 2003; 95(1): 38 - 45. [Abstract] [Full Text] [PDF]

				A Multicenter Evaluation of Assays for Detection of SV40 DNA and Results in Masked Mesothelioma Specimens Cancer Epidemiol. Biomarkers Prev., May 1, 2001; 10(5): 523 - 532. [Abstract] [Full Text]

				R. S. Hamilton, M. Gravell, and E. O. Major Comparison of Antibody Titers Determined by Hemagglutination Inhibition and Enzyme Immunoassay for JC Virus and BK Virus J. Clin. Microbiol., January 1, 2000; 38(1): 105 - 109. [Abstract] [Full Text]

				L. Laghi, A. E. Randolph, D. P. Chauhan, G. Marra, E. O. Major, J. V. Neel, and C. R. Boland JC virus DNA is present in the mucosa of the human colon and in colorectal cancers PNAS, June 22, 1999; 96(13): 7484 - 7489. [Abstract] [Full Text] [PDF]

				J. S. Butel and J. A. Lednicky Cell and Molecular Biology of Simian Virus 40: Implications for Human Infections and Disease J Natl Cancer Inst, January 20, 1999; 91(2): 119a - 134a. [Abstract] [Full Text] [PDF]

				C Mulatero, T Surentheran, J Breuer, and R M Rudd Simian virus 40 and human pleural mesothelioma Thorax, January 1, 1999; 54(1): 60 - 61. [Abstract] [Full Text]

				E. O. Major and J. V. Neel The JC and BK human polyoma viruses appear to be recent introductions to some South American Indian tribes: There is no serological evidence of cross-reactivity with the simian polyoma virus SV40 PNAS, December 22, 1998; 95(26): 15525 - 15530. [Abstract] [Full Text] [PDF]